Get started
Author

Bouchra Badaoui

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML
2017 · Dorothée Selimoglu-Buet, Bouchra Badaoui, et al. · Blood · 77
PDF
Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France
2024 · Vincent Alcazer, Grégoire Le Meur, et al. · The Lancet Digital Health · 46
PDF
Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with an associated inflammatory state
2019 · Sihem Tarfi, Bouchra Badaoui, et al. · Haematologica · 34
PDF
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes
2022 · Elodie Pronier, Aygun Imanci, et al. · Communications Biology · 29
PDF
Exome sequencing for diagnosis of congenital hemolytic anemia
2020 · Lamisse Mansour-Hendili, Abdelrazak Aissat, et al. · Orphanet Journal of Rare Diseases · 28
PDF
Cytokine-like protein 1–induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML
2021 · Margaux Sevin, Franck Debeurme, et al. · Blood · 24
PDF
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML
2021 · Matthieu Duchmann, Orianne Wagner-Ballon, et al. · Leukemia · 14
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia
2024 · Paul Deschamps, Margaux Wacheux, et al. · Journal of Clinical Investigation · 12
PDF
High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening
2017 · Romain Vazquez, Mikael Roussel, et al. · Cytometry Part B Clinical Cytometry · 12
PDF
Cardiovascular risk stratification in hemodialysis patients in the era of highly sensitive troponins: should we choose between hs-troponin I and hs-troponin T?
2015 · Anne-Sophie Bargnoux, Nils Kuster, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 11
Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort
2019 · Erik L. Bao, Caleb A. Lareau, et al. · American Journal of Hematology · 10
PDF
TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia
2023 · Violaine Tran Quang, Benjamin Podvin, et al. · Haematologica · 9
PDF
Multiple thrombosis in a patient with Gardos channelopathy and a new KCNN4 mutation
2021 · Lamisse Mansour‐Hendili, Stéphane Egée, et al. · American Journal of Hematology · 9
PDF
Flow MRD Monitoring Combining Laip/Dfn and CD34+CD38- LSCs Is a Strong Predictor of Outcome in Adult AML Independently of the ELN-2022 Risk: First Results from the Multicentric Acute Leukemia French Intergroup MRD Flow Network
2024 · Adriana Plesa, Stéphanie Mathis, et al. · Blood · 8
PDF
Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study
2020 · Matthieu Jestin, Sihem Tarfi, et al. · Leukemia · 7
Novel inflammatory markers and in‐hospital mortality in epidermal necrolysis—A monocentric study of 137 patients
2022 · Thomas Bettuzzi, Sophie Lalevée, et al. · Journal of the European Academy of Dermatology and Venereology · 6
Acquired spherocytosis due to somatic ANK1 mutations as a manifestation of clonal hematopoiesis in elderly patients
2022 · Lamisse Mansour‐Hendili, Edouard Flamarion, et al. · American Journal of Hematology · 5
Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis
2023 · Saskia Ingen-Housz-Oro, Thomas Bettuzzi, et al. · JAMA Dermatology · 4
AML MRD By Multiparameter Flow Cytometry Using Laip/Dfn and LSC: Methodological Aspects in a Multicentric Study of the French-Flow MRD AML ALFA Network
2022 · Adriana Plesa, Florent Dumezy, et al. · Blood · 4
Reference Values for WBC Differential by Hematoflow Analysis
2018 · Marion Magierowicz, Nicolas Lechevalier, et al. · American Journal of Clinical Pathology · 4
PDF
French national protocol for diagnosis and management of drug reaction with eosinophilia and systemic symptoms (DRESS) in adults and children
2025 · S. Ingen-Housz-Oro, C. Bernier, et al. · Annales de Dermatologie et de Vénéréologie · 3
Development of Machine‐Assisted, Human‐Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic Syndromes
2025 · Kiyoyuki Ogata, Yuto Mochimaru, et al. · eJHaem · 2
PDF
Breaking Free From MCHC Interferences? French‐Speaking Cellular Haematology Group (GFHC) Review of Causes, Rising Trends and Practical Solutions
2025 · Sandrine Girard, Yaël Berda‐Haddad, et al. · International Journal of Laboratory Hematology · 2
PDF
Suivi de la maladie résiduelle dans les leucémies aiguës myéloïdes
2023 · Bouchra Badaoui, Ivan Sloma, et al. · Revue Francophone des Laboratoires · 2
Diagnostic value of three complete blood count abnormalities, hypereosinophilia, hyperlymphocytosis and basophilic lymphocytes, in Drug Reaction with Eosinophilia and Systemic Symptoms
2024 · Patti Carmela Liccardo, Saskia Ingen-Housz-Oro, et al. · British Journal of Dermatology · 1
Works count: 42
Citation count: 365
H-index: 10
I10-index: 11
Year
Topic
Type